Careium AB (publ)

Careium's capital structure is characterized by a debt-to-equity ratio of 0.31, indicating a relatively conservative leverage position. The company holds 54.9 million SEK in cash and equivalents, but its long-term debt of 209.7 million SEK results in a net cash position that is negative after subtracting total debt. The liquidity risk is assessed as medium, with a current ratio of 1.69, suggesting the company can cover its short-term liabilities with its current assets.

Profitability metrics show a return on equity (ROE) of 4.77% and a return on assets (ROA) of 2.98%. These figures are below the industry median for ROE and ROA in the Business Support Services sector, indicating that Careium is underperforming its peers in terms of capital efficiency and asset utilization.

The company's revenue is concentrated in the healthcare equipment and supplies segment, as per its sector classification classification. While geographic exposure is not explicitly detailed in the provided data, the company's primary operations are based in Sweden, and its market share is not yet quantified in the cohort data. This suggests a potential concentration risk if the healthcare equipment market in Sweden experiences a downturn.

Careium's growth trajectory is modest, with the most recent fiscal year showing a revenue of 854.1 million SEK. Analysts estimate the next fiscal year's revenue at 930 million SEK, implying a growth rate of approximately 8.9%. The company's operating income of 49.2 million SEK and net income of 32.5 million SEK suggest a stable but not rapidly expanding business model.

Risk factors include a medium liquidity risk and a low dilution risk. The company's capital expenditures of -92.1 million SEK indicate a net outflow, which could be a sign of investment in long-term assets or a reduction in capital spending. The risk assessment does not highlight any significant dilution potential, and no adjustments have been applied to the valuation metrics.

Recent events include the publication of the latest financial results and analyst estimates. The last actual EPS was 1.33 SEK, while the mean EPS estimate is 1.98 SEK, indicating a potential upside for earnings. The mean EBIT estimate of 72 million SEK suggests a slight improvement in operating performance compared to the actual EBIT of 49.2 million SEK.